Your browser doesn't support javascript.
loading
Specific targeting of the GABA-A receptor α5 subtype by a selective inverse agonist restores cognitive deficits in Down syndrome mice.
Braudeau, J; Delatour, B; Duchon, A; Pereira, P Lopes; Dauphinot, L; de Chaumont, F; Olivo-Marin, J-C; Dodd, R H; Hérault, Y; Potier, M-C.
Affiliation
  • Braudeau J; Centre de Recherche de l'Institut du Cerveau et de Moelle Epinière, CNRS UMR7225, INSERM UMRS 975, UPMC, Paris, France.
J Psychopharmacol ; 25(8): 1030-42, 2011 Aug.
Article in En | MEDLINE | ID: mdl-21693554
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phthalazines / Triazoles / Down Syndrome / Receptors, GABA-A / GABA-A Receptor Agonists Type of study: Etiology_studies Limits: Animals Language: En Journal: J Psychopharmacol Journal subject: PSICOFARMACOLOGIA Year: 2011 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phthalazines / Triazoles / Down Syndrome / Receptors, GABA-A / GABA-A Receptor Agonists Type of study: Etiology_studies Limits: Animals Language: En Journal: J Psychopharmacol Journal subject: PSICOFARMACOLOGIA Year: 2011 Document type: Article Affiliation country: